 |
|
|
| |
HU6 Oral Investigational Therapy Reduces Liver Fat and Improves Adiposity Markers in Adults with MASH: Topline Results from a Phase 2 Randomized Placebo-Controlled Trial (M-ACCEL)
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Presenting Author(s)
Mazen Noureddin
Co-Author(s)
Shaharyar Khan, Rob Schott, Francisco Portell, Edvin Johansson, Arun Sanyal
|
| |
|
|
|
|
|
